• Skip to main content
  • Skip to footer
Eco Friendly CBD OIL

Eco Friendly CBD OIL

The Best Eco Friendly CBD Oil

  • Home
  • CBD Health
  • Cannabis News
  • Contact

CBD OIL

Tip ‘T.I.’ Harris Joins Viola as Social Justice and Reform Ambassador

January 5, 2021 by CBD OIL

Cannabis-infused beverages may only represent a small portion of the overall legal market in the U.S. and Canada now, but there are several reasons to believe that may change, and quickly.

Several companies—from cannabis giants like Canopy Growth and Acreage Holdings to historic, household brands like Pabst Blue Ribbon (PBR)—have placed their bets on cannabis-infused beverages, announcing releases (or plans to) in Q4 2020.

In the case of PBR, which agreed to allow the independently operated Pabst Labs to use its brand for its new THC-based drink, the company and many others are fueling a growing niche within the cannabis beverage niche–THC-infused tonics.

And if the popularity of sparking water brands like La Croix and alcohol-based hard seltzers are any indication, these bubbling beverages may be the drink that takes this edibles segment to the next level.

Poised for Growth

The edibles market represents 15% of all cannabis sales in the U.S., according to a recent webinar hosted by industry research firm BDSA, and beverages make up just a small portion of edibles sales at 5%. In Canada, those figures are 6% and 3%, respectively, according to BDSA. But there is evidence of growing interest.

Of U.S. cannabis consumers, nearly a fifth consume beverages and 8% prefer them, according to BDSA.

A Brightfield Group Q2 2020 survey of 3,500 U.S. cannabis consumers showed similar trends, as ​22% reported consuming a cannabis-infused drink. That’s compared with 57% consuming flower and 41% consuming gummies, according to Brightfield. 

But, “the category has seen significant growth year over year. In Q3 2019, only 14% of cannabis consumers were using drinks,” Bethany Gomez, managing director of Brightfield Group, said in an email to Cannabis Business Times and Cannabis Dispensary. “We do expect this growth trajectory to continue year over year, but given that products are generally sold as a single serve product, the percentage of the overall market is quite low.”

That’s one problem that cannabis beverage brands are trying to solve by offering drinks in multipacks, similar to soda and beer.

The brand Cann Social Tonics, which is available in California, Nevada and Rhode Island, sells its products in six-packs and 24-can “party packs.” The idea was to make a drink that looks and feels just like any other beverage you’d take to a party and share with others, mimicking other consumer packaged goods, said Cann co-founder Luke Anderson in an interview with Cannabis Business Times and Cannabis Dispensary in September.

“I think carbonated beverages are having a moment,” Anderson said. “The sparkling water market’s evolution over the last few years is a sign of people looking for something that has a little bite to it and a little bit of texture. So we want [Cann] to integrate in the same social settings and have people think about them the same way they do a beer, a light beer, a hard seltzer or a craft cocktail in a can.”

Part of the challenge was making something that wasn’t overly sweet taste good, and not relying on “hundreds of calories to mask the taste of cannabis,” said Cann co-founder Jake Bullock. They also wanted to create a beverage that allowed people to control their dosages more easily and where they could enjoy a couple and not be overly intoxicated.

“If you think about products like other mild intoxicants—caffeine, alcohol—we consume them in a beverage, and most importantly, in that beverage, we consume them in a microdose,” Bullock said. “We’re not running around drinking eight shots of espresso or Everclear grain alcohol. When you bring the dosing way down, it becomes approachable for new consumers, it becomes social, it can integrate and behaves as the same strength as a glass of wine or a light beer.”

Cann offers flavors such as lemon lavender, grapefruit rosemary and blood orange cardamom, and each can contains 2 mg of THC and 35 calories, one of the lowest in both categories in the cannabis beverage market. According to BDSA, Cann is now the third highest-selling cannabis beverage in legal markets in the U.S. 

“That’s really our vision is just to continue to produce approachably dosed, nothing more than five milligrams, THC beverages that welcome in a whole new wave of consumers,” Anderson says.

Familiar Brands Fuel Acceptance

Combining cannabis with a familiar “form factor,” beverages are one avenue to further destigmatize cannabis use and can attract consumers who may not be comfortable with smoking, vaping or other consumption methods. When you integrate a brand that’s been around for 175 years with cannabis, that can encourage people who may be unfamiliar with cannabis or had a bad experience in the past to try again, said Austin Stevenson, chief innovation officer of Vertosa, which helped develop Lagunitas Hi-Fi Hops, a “hoppy sparkling water,” and Pabst Blue Ribbon Cannabis-Infused Seltzer. 

“PBR is over 175 years old, and so what having a brand like PBR does is it crosses generations of cannabis consumers,” Stevenson said. “We know, aside from millennials, that people over the age of 55 are one of the fastest-growing segments of cannabis consumers, and to be able to have your 20-something-year-old get a PBR and go home to their grandparents and say, ‘Look, here is the brand that you grew up consuming,’ but now with a cannabis function, it only helps to normalize and destigmatize the industry.”

Mark Faicol, brand manager of Pabst Labs, which was founded by a group of beverage experts and former PBR employees, said although one target customer is brand loyalists, he sees PBR further contributing to the wider acceptance of cannabis.

“We have a unique—call it competitive, advantage—but really a history in the market, being around for so long … as a trusted well-respected brand,” Faicol said, adding that Pabst Labs has the opportunity to leverage that.

Pabst Labs launched its cannabis-infused seltzer in California with one simple, “easy to understand” flavor – lemon, which is also part of the company’s strategy to appeal to a diverse, wide audience. Each can contains 5 mg of THC, 4 grams of sugar and just 25 calories, and they come in four-packs. Although more flavors may be introduced, Faicol said the initial goal was to, “Do one thing, and do it well, and really be very simple and approachable. Lemon is [a flavor] that is very sessionable and most widely accepted, at least that’s what our data pointed toward.”

Responsible dosing was another focus for the company, Faicol said. Although many consumers still purchase based on price per milligram in an attempt to get the most value out of products, that can lead to negative experiences. He also points out that while people may have had one – or many – hangovers, they continue to drink alcohol, but one bad cannabis experience can drive a consumer away for good.

“That’s something that the brands in beverages are really kind of working together on, to educate on proper dosing,” Faicol said. “And I think it will only help the category at large.”

While more consumers may be coming on board, there are challenges in distribution logistics and placement in dispensaries, especially in legacy markets that were built to merchandise flower, edibles and other traditional products, and may not be configured to include refrigerators displaying drinks, Stevenson said.  

“They weren’t built like a 7-Eleven for beverages,” Stevenson said. “They haven’t invested in it. They don’t have the floor space either because of regulations … or those investments haven’t been there.”

However, as newer markets in the Midwest and East Coast continue to grow, Stevenson says he sees new opportunities to encourage cannabis companies to build and develop dispensaries with beverages in mind—and get the buy-in from regulators, too.

“[Vertosa] is looking at Illinois, at Michigan, Massachusetts, these big beer-drinking markets where they’re getting cannabis regulation for the first time. When we have brands like Lagunitas, like PBR, when we enter these new markets, we want to make sure that the consumer retail experience highlights these opportunities to have a more approachable type of product,” he said. “In these new markets, you’re going to build retail experiences that have cooler spaces that have displays. I work at both the state level and the local level on some regulatory policies to help promote and make consumers and business operators aware that cannabis beverage is here, but the retail channel needs to be able to support product placement like any other traditional retailer.”

Catering to Experienced Consumers

While low-dose beverages can serve as an entry point for those who are curious but hesitant to try cannabis, offering a wide variety of products is important to reach the more seasoned consumer, too, Stevenson said.

“For your introductory consumer, you’re going to go with a low-dose product, 5 milligrams of THC, and that can be had any time during the day,” Stevenson said. “Now how you differentiate is you look at the [Lagunitas] Hi-Fi Hops portfolio, and they have a THC product that is 10 milligrams, and then they also have a CBD product that’s [18 milligrams CBD]. And so the CBD product is more for the relaxation.

“And so by building a beverage portfolio, that’s how you start to address the different consumer functional needs by changing the different ratios of cannabinoids of THC versus CBD or high-dose versus low-dose.”

Brightfield Group’s Bethany Gomez said thinking about who your consumer is and how they want to experience your product is important when building a brand.

“If you are pitching [a] cannabis beverage as an alcohol substitute, it needs to be effectively positioned for the same occasions that people are using alcohol,” Gomez said in an email. “But many consumers use cannabis and alcohol quite differently, in different [times of day] or during different moments of consumption, [such as] before a workout or to inspire creativity, which makes it not as straightforward a substitute.”  

However, just because a beverage is marketed a certain way doesn’t mean that’s how it will be consumed. Take the example of Cann. Although the founders couldn’t predict the coronavirus pandemic nor the effect on sales of a drink they envisioned being a “social” tonic, it did not have a negative effect on company growth, Anderson said. 

“The toughest part of this company was the first year on market, our sales were relatively flat. Consumers loved the product, but they couldn’t really understand how to think about it because alcohol was dominating their social [lives] and bars were open,” he said. “You could have a Cann at a pregame. You could have a Cann on a weeknight, but come Friday, you’re trained to go out and you’re trained to just drink whatever is available to you on tap.”

Once states began instituting stay-at-home orders and closing bars, that’s when things changed, Anderson said. Sales increased 10 times what they were before the pandemic, he said. 

“This idea that people were buying a bunch of cannabis to ease their anxiety was the first wave of the sales spike,” Anderson said. “People were enjoying the fact they could feel a buzz and hang out and laugh and have a good time, but not feel like crap the next day.”

Paying attention to these consumer preferences and how they evolve is an important part of driving innovation and sales, Faicol said. 

“[PBR] made a conscious decision to change. We’re a beer brand through and through, but we made a decision many years back that, the consumer is going to want something else. And America is going to look very different … five years from now,” Faicol said. “But I think that’s going to be a critical driver, is the ability for brands to continue to innovate, and really keep it exciting, which we’re committed to do.”

This article has been updated from its original version to clarify that Hi-Fi Hops is a nonalcoholic, hoppy cannabis-infused sparkling water, not a nonalcoholic, cannabis-infused beer. 

Filed Under: Cannabis News

New Colorado Marijuana Rules Go Into Effect on Jan. 1, 2021

January 5, 2021 by CBD OIL

When Mike Howard (Director of Cultivation, The Grove) first caught word of the record-breaking cannabis yields being harvested regularly by fellow grow teams around the country (Lume Cannabis in Michigan and Green Life Productions in Nevada) he knew the game was changing. Once Howard dug deeper into the news, he discovered a common catalyst behind the success of his peers: both facilities were actively growing under the A3i LED grow light from Fohse. After hearing firsthand from the grow teams in Michigan and Nevada how they had increased yields over HPS by 31% and 100% respectively, Howard knew he had to get Fohse lighting into The Grove … and fast!

The Grove, a vertically integrated cannabis business with dispensary, cultivation, distribution, and production licenses, has been producing, sourcing, and selling high quality edibles, cartridges, and recreational cannabis products since 2015. Their 26,600-square-foot growing and production facility is state-of-the-art and eco-friendly. They strive to recreate the conditions that cannabis would find in nature and use only all-natural growing media and inputs as well as biological measures to control any pests or diseases. It only makes sense then that they would seek out and select Fohse products – the best lighting fixtures in the business – to match The Grove’s exacting standards.

The dry Las Vegas air makes for a challenging indoor growing environment for cannabis. Fohse fixtures operate at much cooler temperatures than standard HPS fixtures. At The Grove, this means that the humidifiers and cooling systems don’t have to work as hard, and that an equilibrium between temperature and humidity level can be more easily achieved and maintained. This has led to some of the record harvests being seen regularly at The Grove. Looking at how Fohse’s A3i 1500-watt fixtures compare to standard 1000-watt DE HPS fixtures in an “apples to apples” comparison reveals just how in sync these intelligent fixtures are with cannabis. The numbers from a recent, late fall harvest tell an impressive tale:

  A3i 1500W LED 1000W DE HPS
Total Fixtures 35 64
Total Plant Count 520 520
Grow Media Coco pots Coco pots
Grow Area 1056 sf 1056 sf
Flower Cycle 65 days 65 days
PPFD (early flower) 800-820 800-820
PPFD (late flower) 1250-1350 1000-1050
Wet weight 1,392 lbs. (631.4 kg) 716 lbs. (324.8 kg)
Dry Weight 223 lbs. (101.3 kg) 135 lbs. (61.2 k g)
Yield in oz./ Square Foot 3.4 oz (96 g) 2.05 oz (58 g)
Lbs. of Cannabis/Light Fixture* 6.57 lbs. (2.98 kg) 2.11 lbs. (.96 kg)
Total kWh 41,072 49,155

*Strawberry Cheesecake was the highest-yielding strain at 7.2 lbs/light, while Cookies was the lowest at 5.49 lbs/light

In the now-typical example above from Fall 2020, the A3i system generated an average of 27 percent more light as compared to the HPS fixtures. This additional light led to an increase in dry yield harvest weights by a whopping 65 percent. All of this, while using 16 percent less energy than the HPS lighting it was compared to and in the same physical footprint of space with the same number of plants.

Remarkable results like those at The Grove are not a fluke or an accident and they are not restricted to Mike Howard and his team alone. Growers all over are finding results like these to be the new norm, regardless of growing media and style of growing. Lume Cannabis has been tracking results of their Fohse A3i fixtures for over 40 hydroponic growing cycles and across 8 different strains of cannabis. Without fail, the team at Lume under Kevin Kuethe’s direction, reports higher yields under the A3i than those grown under HPS. For example, with Fohse fixtures they have harvested 7,130 lbs. versus 5,241 lbs. with the same strains grown under HPS. THC levels under Fohse lights have been 3 percent higher too; 20 percent versus 17 percent on average. In other words, the cannabis that Lume grew under Fohse lighting netted more than $2.5 million more than the cannabis grown under HPS.

Steve Cantwell at Green Life Productions also reports unbelievable differences since switching over to Fohse’s A3i and F1V fixtures as well. Green Life Production’s typical harvests under their previous lighting system was 80-90 lbs. The average harvest now using Fohse fixtures is 160 to nearly 200 lbs pulled from his 4×8, no-till, living, organic soil beds. Like Mike Howard’s team at The Grove, Steve and his team have the enviable logistics problem of figuring out where to put all of the bounty from these sky-high yields. All three teams, The Grove (coco pots), Lume Cannabis (hydroponics) and Green Life Productions (live soil), are blowing harvest records out of the water time and time again across three drastically different cultivation styles. These highly regarded and experienced cannabis producers are showing that the rules have changed and that Fohse lighting fixtures enable previously unobtainable and unthinkable results.

grove

@Keene.Media

The Grove

Howard and the grow team at The Grove have achieved their amazing results by relying on the horticultural skills of their talented team, and also by utilizing two of Fohse’s premier products. They have predominantly been using the A3i model, Fohse’s workhorse grow light, to achieve their highest yields. The A3i is specifically designed to grow cannabis and that is exactly what it does. Its spectral distribution is custom-made to address the unique needs of cannabis. As evidenced in the remarkable yields outlined in the table above, the A3i’s output (of up to 4,970 µmol/s depending on configuration) can be adjusted to supply seasonably appropriate lighting depending on the growth phase of the crop. All of this while producing up to 156 percent more light per fixture and burning cooler (no hotter than dishwashing water) than traditional HPS grow lights. This means the A3i is safer to operate for both growers and their cannabis crops.

The A3i system is designed to handle the harsh extremes of a growing environment. The IP67-rated fixture will continue to operate at peak performance even with the moisture, dust, pests, and biological debris such as spores that are present in most indoor growing environments. Not many growers would expect their grow lights to still perform well after being submerged under several feet of water; the A3i can survive such a plunge and be relied on to deliver its photon payload as designed. Howard and his team at The Grove do not just rely on the A3i for their high yields. In their double-stack rooms they deploy Fohse’s lighter, more nimble F1V for its pound-for-pound power.

Just like the A3i, the F1V fixtures rely on industry-proven Samsung LEDs for their photon delivery. While almost the same dimensions as the A3i, at 38 pounds (17.2 kg) per fixture they are almost half the weight of each A3i (70 lbs./31.75kg each). Like the A3i fixtures, their power supply rating is +100,000 hours. Depending on the needs of the grower and the ability of the existing systems, Fohse offers 420W, 600W, and 800W versions of the F1V. In his own F1V rooms, Howard has reported similarly positive results as in his A3i rooms: 60%+ yield increases, increased utility efficiencies, and better labor efficiency. The team now does not have to “chase canopy” by raising and lowering the lighting fixtures to achieve late-flower PPFD intensities like they did with the old LED lights that they were using in those double-tiered systems.

Fohse lighting products outperform their competition not only at the Grove, but anywhere they have been put to the test. So why hasn’t every cannabis grower switched over to Fohse? Growers who have not yet seen the results firsthand still believe that LEDs cannot keep up with the high lighting demands of cannabis the way that HPS lighting traditionally has. The narrative had long been one of incremental change and an acceptance that two pounds of harvested yields per light fixture was the best one could expect. At the turn of the century, there was chatter that this didn’t have to be ‘good enough’. By 2015 growers both professional and amateur alike had proven that three pounds per light was achievable based on advancements up to that point, but no one thought it would ever get better than that. Until Fohse set out to prove them all wrong, and then did. They showed that higher light output does not have to mean higher heat and that Diode technology had come a long way in just a few short years. Mike Howard gives his take on this phenomenon:

“Everyone looks at LED lighting as still kind of a novelty; not something where it needs to be yet for cannabis growers. Having seen the evolution of LEDs that the Fohse team has created because of their cannabis mindset, it became obvious that we could focus on producing healthy plants.  A lot of other grow lighting companies are still looking at making and selling lights that can grow anything. Cannabis takes a lot of light and many companies and even growers don’t put enough light into commercial setups. Many cannabis growers never thought that LED technology was ever going to make it, but the power that comes out of Fohse fixtures is insane. Fohse lighting lets the grower focus on plant health and our yields show that. With Fohse LEDs, overtaking HPS, you can really push the limits of your grow.”

As Mike Howard said, Fohse fixtures are engineered with a “cannabis mindset”. HPS Light output has plateaued because the added heat load is both detrimental to the cannabis crop and uneconomical to counterbalance. With Fohse fixtures growers can focus more on the nuances of a high-intensity light environment instead of combatting heat. Ever since that first time Mike Howard oversaw production in the initial grow room where Fohse products were installed at the Grove, he immediately saw the results. He is now vowing to keep replacing The Grove’s less efficient HPS fixtures and outdated LEDs with Fohse lighting as they continue expanding. Find out how switching to Fohse fixtures will increase your cannabis production and about all of Fohse’s record-busting lighting at Fohse.com.

 

Filed Under: Cannabis News

Missouri Lawmaker Introduces Legislation to Place Adult-Use Cannabis Legalization on 2022 Ballot

January 5, 2021 by CBD OIL

CHICAGO–(BUSINESS WIRE)–PRESS RELEASE–Cresco Labs, one of the largest vertically integrated, multistate cannabis operators in the United States, has published the first annual report for its SEED (Social Equity and Educational Development) initiative. The report highlights the company’s many achievements over the past year to help create a more diverse and inclusive cannabis industry through SEED’s restorative justice initiatives, community business incubators, and educational and workforce development programming. The 2019-2020 SEED Annual Report is available online at crescolabs.com/seed.

“We are proud to have launched the cannabis industry’s first comprehensive social justice and social equity initiative and to report the significant strides the SEED program has made towards the more equitable inclusion of Black and Brown people in cannabis,” said Charlie Bachtell, CEO and co-founder of Cresco Labs. “As we reflect on SEED’s first year successes, we recognize that this is just the beginning of a long road ahead and a tremendous amount of work is still to be done. Our goal is to provide the time, know-how and resources to elevate more voices and foster economic opportunities for people from communities disproportionately impacted by prior drug laws. The ability of this industry to reach its maximum potential will be governed by its ability to address the social responsibility components tied to this subject matter. Our SEED team is made up of incredibly talented, hard-working individuals who are building a culture where all Cresco Labs employees are inspired to improve inclusiveness within the cannabis industry. Our SEED initiative supports our vision to be the most important company in cannabis and is helping to build the most responsible and respectable industry possible. Together, we are firmly committed to continuing the progress we’ve achieved this inaugural year into the future.”

The SEED Annual Report outlines the mission of SEED, describes its goals and initiatives, and details the efforts dedicated to the program’s success. Highlights of the 2019/2020 program include:

  • Invested over $1.5M and contributed over 2,200 Cresco Labs staff hours for more than 40 multi-tiered SEED initiatives
  • Sponsored and financially supported 22 restorative-focused events and more than 1,200 individuals seeking expungement of their records
  • Conducted SEED’s inaugural Community Business Incubator that assisted 50 businesses and over 250 individuals in total over two application periods in Illinois
  • Established 8 community and workforce development initiatives and assisted in the development of cannabis industry curriculum with 5 universities and colleges

Cresco Labs’ SEED team was the recipient of the 2020 Bill Leslie Visionary Award from Cabrini Green Legal Aid, a nonprofit established in 1973 to serve legal needs arising from the lack of opportunity, criminalization of poverty, and racial inequity experienced within the Cabrini Green community in Chicago, Illinois. This recognition reinforces the SEED initiative’s effort to build community relationships and do its part to be restorative and inclusive.

In May 2019, Cresco Labs created SEED to address the absence of people, businesses and communities disproportionately impacted by the War on Drugs in the cannabis industry. Its mission is to develop tangible pathways into the cannabis industry for communities impacted by the War on Drugs through the three pillars of SEED: Restorative Justice, Community Business Incubator, and Education & Workforce Development. SEED’s restorative justice programming includes expungement events, lobbying to change the nation’s drug laws, and working to ensure that no person remains in prison for a cannabis conviction. Established in November 2019, Cresco’s Community Business Incubator provides qualifying social equity applicants with the resources, knowledge and guidance needed to successfully apply for adult use dispensary licenses awarded by the Illinois Department of Financial and Professional Regulation. SEED develops educational cannabis programming tailored to communities disproportionately impacted by the War on Drugs, as well as builds collaborative relationships with colleges and universities to develop curriculum, teach classes and host workshops to educate and prepare students for careers in cannabis.

Filed Under: Cannabis News

Alabama Lawmaker Plans to Reintroduce Medical Cannabis Legalization Bill

January 5, 2021 by CBD OIL

CHICAGO–(BUSINESS WIRE)–PRESS RELEASE–Cresco Labs, one of the largest vertically integrated, multistate cannabis operators in the United States, has published the first annual report for its SEED (Social Equity and Educational Development) initiative. The report highlights the company’s many achievements over the past year to help create a more diverse and inclusive cannabis industry through SEED’s restorative justice initiatives, community business incubators, and educational and workforce development programming. The 2019-2020 SEED Annual Report is available online at crescolabs.com/seed.

“We are proud to have launched the cannabis industry’s first comprehensive social justice and social equity initiative and to report the significant strides the SEED program has made towards the more equitable inclusion of Black and Brown people in cannabis,” said Charlie Bachtell, CEO and co-founder of Cresco Labs. “As we reflect on SEED’s first year successes, we recognize that this is just the beginning of a long road ahead and a tremendous amount of work is still to be done. Our goal is to provide the time, know-how and resources to elevate more voices and foster economic opportunities for people from communities disproportionately impacted by prior drug laws. The ability of this industry to reach its maximum potential will be governed by its ability to address the social responsibility components tied to this subject matter. Our SEED team is made up of incredibly talented, hard-working individuals who are building a culture where all Cresco Labs employees are inspired to improve inclusiveness within the cannabis industry. Our SEED initiative supports our vision to be the most important company in cannabis and is helping to build the most responsible and respectable industry possible. Together, we are firmly committed to continuing the progress we’ve achieved this inaugural year into the future.”

The SEED Annual Report outlines the mission of SEED, describes its goals and initiatives, and details the efforts dedicated to the program’s success. Highlights of the 2019/2020 program include:

  • Invested over $1.5M and contributed over 2,200 Cresco Labs staff hours for more than 40 multi-tiered SEED initiatives
  • Sponsored and financially supported 22 restorative-focused events and more than 1,200 individuals seeking expungement of their records
  • Conducted SEED’s inaugural Community Business Incubator that assisted 50 businesses and over 250 individuals in total over two application periods in Illinois
  • Established 8 community and workforce development initiatives and assisted in the development of cannabis industry curriculum with 5 universities and colleges

Cresco Labs’ SEED team was the recipient of the 2020 Bill Leslie Visionary Award from Cabrini Green Legal Aid, a nonprofit established in 1973 to serve legal needs arising from the lack of opportunity, criminalization of poverty, and racial inequity experienced within the Cabrini Green community in Chicago, Illinois. This recognition reinforces the SEED initiative’s effort to build community relationships and do its part to be restorative and inclusive.

In May 2019, Cresco Labs created SEED to address the absence of people, businesses and communities disproportionately impacted by the War on Drugs in the cannabis industry. Its mission is to develop tangible pathways into the cannabis industry for communities impacted by the War on Drugs through the three pillars of SEED: Restorative Justice, Community Business Incubator, and Education & Workforce Development. SEED’s restorative justice programming includes expungement events, lobbying to change the nation’s drug laws, and working to ensure that no person remains in prison for a cannabis conviction. Established in November 2019, Cresco’s Community Business Incubator provides qualifying social equity applicants with the resources, knowledge and guidance needed to successfully apply for adult use dispensary licenses awarded by the Illinois Department of Financial and Professional Regulation. SEED develops educational cannabis programming tailored to communities disproportionately impacted by the War on Drugs, as well as builds collaborative relationships with colleges and universities to develop curriculum, teach classes and host workshops to educate and prepare students for careers in cannabis.

Filed Under: Cannabis News

Illinois Governor Expunges Nearly Half a Million Cannabis Records

January 5, 2021 by CBD OIL

Missouri Rep. Shamed Dogan has filed legislation that would place an adult-use cannabis legalization measure on the state’s 2022 ballot, according to the St. Louis Post-Dispatch.

The measure, House Joint Resolution 30, is a constitutional amendment. It would leave Missouri’s medical cannabis program intact, but would repeal the text of the 2018 constitutional amendment that legalized medical cannabis, which would ultimately scrap the state’s controversial licensing process and limited license structure, the St. Louis Post-Dispatch reported.

Instead, Dogan’s proposal would set up a cannabis licensing process that is similar to licensing any other business in the state, according to the news outlet.

The measure also directs the state to release anyone incarcerated for “non-violent, marijuana only offenses that are no longer illegal in the state of Missouri,” the St. Louis Post-Dispatch reported, as well as to stop monitoring those on probation or parole for those offenses.

In addition, the proposal would require Missouri courts to expunge civil and criminal records related to “all non-violent, marijuana-only offenses that are no longer illegal” within 60 days of the ballot measure’s passage, according to the St. Louis Post-Dispatch.

The measure would levy a 12% tax on adult-use cannabis and a 4% tax on medical cannabis, the news outlet reported, and the revenue generated would be directed to the Smarter and Safer Missouri Fund, which would support the Missouri Veterans Commission, infrastructure projects and drug treatment programs.

Meanwhile, Missourians for a New Approach has announced plans for a 2022 ballot initiative to legalize adult-use cannabis after an unsuccessful signature campaign to get the issue before voters in 2020.

Filed Under: Cannabis News

Florida Bill Would Reduce Doctor Visits for Medical Cannabis Patients

January 4, 2021 by CBD OIL

CHICAGO–(BUSINESS WIRE)–PRESS RELEASE–Cresco Labs, one of the largest vertically integrated, multistate cannabis operators in the United States, has published the first annual report for its SEED (Social Equity and Educational Development) initiative. The report highlights the company’s many achievements over the past year to help create a more diverse and inclusive cannabis industry through SEED’s restorative justice initiatives, community business incubators, and educational and workforce development programming. The 2019-2020 SEED Annual Report is available online at crescolabs.com/seed.

“We are proud to have launched the cannabis industry’s first comprehensive social justice and social equity initiative and to report the significant strides the SEED program has made towards the more equitable inclusion of Black and Brown people in cannabis,” said Charlie Bachtell, CEO and co-founder of Cresco Labs. “As we reflect on SEED’s first year successes, we recognize that this is just the beginning of a long road ahead and a tremendous amount of work is still to be done. Our goal is to provide the time, know-how and resources to elevate more voices and foster economic opportunities for people from communities disproportionately impacted by prior drug laws. The ability of this industry to reach its maximum potential will be governed by its ability to address the social responsibility components tied to this subject matter. Our SEED team is made up of incredibly talented, hard-working individuals who are building a culture where all Cresco Labs employees are inspired to improve inclusiveness within the cannabis industry. Our SEED initiative supports our vision to be the most important company in cannabis and is helping to build the most responsible and respectable industry possible. Together, we are firmly committed to continuing the progress we’ve achieved this inaugural year into the future.”

The SEED Annual Report outlines the mission of SEED, describes its goals and initiatives, and details the efforts dedicated to the program’s success. Highlights of the 2019/2020 program include:

  • Invested over $1.5M and contributed over 2,200 Cresco Labs staff hours for more than 40 multi-tiered SEED initiatives
  • Sponsored and financially supported 22 restorative-focused events and more than 1,200 individuals seeking expungement of their records
  • Conducted SEED’s inaugural Community Business Incubator that assisted 50 businesses and over 250 individuals in total over two application periods in Illinois
  • Established 8 community and workforce development initiatives and assisted in the development of cannabis industry curriculum with 5 universities and colleges

Cresco Labs’ SEED team was the recipient of the 2020 Bill Leslie Visionary Award from Cabrini Green Legal Aid, a nonprofit established in 1973 to serve legal needs arising from the lack of opportunity, criminalization of poverty, and racial inequity experienced within the Cabrini Green community in Chicago, Illinois. This recognition reinforces the SEED initiative’s effort to build community relationships and do its part to be restorative and inclusive.

In May 2019, Cresco Labs created SEED to address the absence of people, businesses and communities disproportionately impacted by the War on Drugs in the cannabis industry. Its mission is to develop tangible pathways into the cannabis industry for communities impacted by the War on Drugs through the three pillars of SEED: Restorative Justice, Community Business Incubator, and Education & Workforce Development. SEED’s restorative justice programming includes expungement events, lobbying to change the nation’s drug laws, and working to ensure that no person remains in prison for a cannabis conviction. Established in November 2019, Cresco’s Community Business Incubator provides qualifying social equity applicants with the resources, knowledge and guidance needed to successfully apply for adult use dispensary licenses awarded by the Illinois Department of Financial and Professional Regulation. SEED develops educational cannabis programming tailored to communities disproportionately impacted by the War on Drugs, as well as builds collaborative relationships with colleges and universities to develop curriculum, teach classes and host workshops to educate and prepare students for careers in cannabis.

Filed Under: Cannabis News

WeedMD Announces CEO Leadership Transition and New Board Appointment

January 4, 2021 by CBD OIL

<![CDATA[

TORONTO, Jan. 04, 2021 (GLOBE NEWSWIRE) — PRESS RELEASE — WeedMD Inc., a federally-licensed producer and distributor of medical-grade cannabis, has announced that its board of directors has appointed executive chairman, George Scorsis, as interim Chief Executive Officer, effective immediately. This appointment follows Angelo Tsebelis’s decision to step down from his CEO and director roles, with mutual agreement from the Board, following the successful year-long integration of WeedMD and Starseed Holdings Inc. Tsebelis has agreed to take an advisory role to help the company through this period of transition.

The company is now leading a comprehensive search process to select a permanent CEO. Concurrently, WeedMD announced today that Jason Alexander, the company’s Chief Legal Officer, has been appointed as a director and has joined the Board pursuant to the terms of the company’s nomination rights and voting agreement dated Dec. 20, 2019.

RELATED: WeedMD’s Bold Pivot in Canada’s Evolving Market

“On behalf of the Board, we thank Angelo for his leadership, focus and guidance during a complex period as we combined two companies and navigated a dynamic landscape that resulted from the worldwide pandemic last year,” said Scorsis. “Angelo was integral in merging our businesses, optimizing our operations, commercializing our sales and distribution initiatives and bringing a renewed focus on brand awareness. During his tenure, WeedMD achieved a two-fold sales increase in the first nine months of 2020, compared to the full year 2019. We appreciate his contributions to our growth, his counsel during our transition and we wish him well on his future endeavours.”

Scorsis added, “I am also pleased to welcome Jason Alexander as the newest director to our Board. Jason was instrumental in working alongside Angelo and the leadership team to fully-integrate the company into a position of strength over the past year. Moving forward, WeedMD is now anchored in the best cultivation, commercial and product frameworks in Canada as we work to accelerate our profitability goals. Together we are kicking off 2021 with a focused approach on increasing market share and commercial growth of our Color Cannabis and Saturday brands, while expanding our medical footprint through our Starseed portfolio. This includes an aggressive plan to transition WeedMD into a consumer-facing model of excellence. Ultimately becoming hyper-focused on driving meaningful results, while optimizing the organization for future success to deliver shareholder value.”

Alexander, as Chief Legal Officer, has been part of the organization since 2018 and was instrumental in the acquisition by WeedMD and Starseed. He oversees all areas of corporate performance including compliance, quality assurance, risk, legal and corporate affairs and served as Corporate Secretary of the company over the past two years. With over 15 years of senior corporate experience navigating complex transactions and commercial matters, Alexander was previously Chief Legal Officer of Starseed, legal counsel for Shoppers Drug Mart and a corporate lawyer at Miller Thomson LLP.

Scorsis, with nearly 20 years of commercial experience in the consumer packaged goods (CPG), beverage and the cannabis industries, has been a vital member of the Board since 2019 and is widely recognized for building high-performing teams. As former CEO and director of Liberty Health Sciences, Scorsis led that company’s expansion into the U.S.-medical cannabis market. He also served as the president of one of Canada’s first public cannabis companies, Mettrum Health Corp., where he was instrumental in a successful exit valued at approximately $430 million. Prior to joining the cannabis industry, Scorsis was General Manager of Red Bull Canada where he helped restructure that company geographically, increasing business revenues by $150 million annually.

]]>

Filed Under: Cannabis News

Case Report: Striking Lung Cancer Response to Cannabidiol

January 4, 2021 by CBD OIL

Lung cancer is one of the leading causes of cancer deaths in the US. Fortunately, new potential weapons against this cancer are still being discovered. And one of them may include cannabidiol (CBD).

Although this cannabinoid has not yet been studied extensively to completely understand its potential cancer-fighting capabilities, there is evidence that cannabinoids may be a formidable treatment for certain types of cancer.

CBD has been shown to induce controlled cell death, or apoptosis, in cancer in a dose-dependent manner.[1] CBD can also be quite detrimental to a specific pathway that plays an important role in the growth of cancer cells.[2] And there are several additional studies that have found similar results in lung cancer. However, these studies have been conducted in pre-clinical models, not humans.

A case review published in the journal SAGE Open Medical Case Reports described details an 81-year-old ex-smoker with a history of prostate cancer (in remission), chronic obstructive pulmonary disorder (COPD), and diet-controlled diabetes.[3] In October 2016, he was found to have a 2.5×2.5 cm mass in his lower left lung and many lymph nodes. The mass had grown to a 2.7×2.8 cm by that December.

However, almost a year later, the patient’s CT scan showed that the mass had almost completely resolved itself and that only a small spot of soft tissue remained, measuring 1.3×0.6 cm.

The patient relayed to doctors that he had started taking CBD oil from the beginning of September 2017. The product contained 2% CBD (200mg in 10 mL of a carrier oil). His dosage was two drops (0.06 mL; 1.32 mg CBD) two times per day for one week, and then he increased the dosage to nine drops (0.3 mL; 6 mg CBD) twice each day through September.

Although this represents a single case study, these data are promising and indicative that CBD could be an effective weapon against lung cancer in humans.

But, before it can be widely used by the health care industry, much more work is necessary to truly determine the precise nature and effects of CBD on lung malignancies as well as other forms of cancer.

Talk to your oncologist if you are interested in using CBD or medical cannabis as part of your cancer treatment plan.

Image Credit: Anna Shvets

Image Source: https://www.pexels.com/photo/man-people-woman-internet-4225877/

References

  1. Choi WH, et al. Cannabidiol induces cytotoxicity and cell death via apoptotic pathway in cancer cell lines. Biomolecules and Therapeutics. 2008;16(2):87-94.
  2. Elbaz, M, et al. Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of cannabidiol in breast cancer. Molecular Oncology.2015;9(4):906-919.
  3. Sulé-Suso J, et al. Striking lung cancer response to self-administration of cannabidiol: A case report and literature review. SAGE Open Medical Case Reports. 2019.

Filed Under: CBD Health

Adult-Use Cannabis Legalization Bill Delayed in New Jersey

January 4, 2021 by CBD OIL

TORONTO, Jan. 04, 2021 (GLOBE NEWSWIRE) — PRESS RELEASE — WeedMD Inc., a federally-licensed producer and distributor of medical-grade cannabis, has announced that its board of directors has appointed executive chairman, George Scorsis, as interim Chief Executive Officer, effective immediately. This appointment follows Angelo Tsebelis’s decision to step down from his CEO and director roles, with mutual agreement from the Board, following the successful year-long integration of WeedMD and Starseed Holdings Inc. Tsebelis has agreed to take an advisory role to help the company through this period of transition.

The company is now leading a comprehensive search process to select a permanent CEO. Concurrently, WeedMD announced today that Jason Alexander, the company’s Chief Legal Officer, has been appointed as a director and has joined the Board pursuant to the terms of the company’s nomination rights and voting agreement dated Dec. 20, 2019.

RELATED: WeedMD’s Bold Pivot in Canada’s Evolving Market

“On behalf of the Board, we thank Angelo for his leadership, focus and guidance during a complex period as we combined two companies and navigated a dynamic landscape that resulted from the worldwide pandemic last year,” said Scorsis. “Angelo was integral in merging our businesses, optimizing our operations, commercializing our sales and distribution initiatives and bringing a renewed focus on brand awareness. During his tenure, WeedMD achieved a two-fold sales increase in the first nine months of 2020, compared to the full year 2019. We appreciate his contributions to our growth, his counsel during our transition and we wish him well on his future endeavours.”

Scorsis added, “I am also pleased to welcome Jason Alexander as the newest director to our Board. Jason was instrumental in working alongside Angelo and the leadership team to fully-integrate the company into a position of strength over the past year. Moving forward, WeedMD is now anchored in the best cultivation, commercial and product frameworks in Canada as we work to accelerate our profitability goals. Together we are kicking off 2021 with a focused approach on increasing market share and commercial growth of our Color Cannabis and Saturday brands, while expanding our medical footprint through our Starseed portfolio. This includes an aggressive plan to transition WeedMD into a consumer-facing model of excellence. Ultimately becoming hyper-focused on driving meaningful results, while optimizing the organization for future success to deliver shareholder value.”

Alexander, as Chief Legal Officer, has been part of the organization since 2018 and was instrumental in the acquisition by WeedMD and Starseed. He oversees all areas of corporate performance including compliance, quality assurance, risk, legal and corporate affairs and served as Corporate Secretary of the company over the past two years. With over 15 years of senior corporate experience navigating complex transactions and commercial matters, Alexander was previously Chief Legal Officer of Starseed, legal counsel for Shoppers Drug Mart and a corporate lawyer at Miller Thomson LLP.

Scorsis, with nearly 20 years of commercial experience in the consumer packaged goods (CPG), beverage and the cannabis industries, has been a vital member of the Board since 2019 and is widely recognized for building high-performing teams. As former CEO and director of Liberty Health Sciences, Scorsis led that company’s expansion into the U.S.-medical cannabis market. He also served as the president of one of Canada’s first public cannabis companies, Mettrum Health Corp., where he was instrumental in a successful exit valued at approximately $430 million. Prior to joining the cannabis industry, Scorsis was General Manager of Red Bull Canada where he helped restructure that company geographically, increasing business revenues by $150 million annually.

Filed Under: Cannabis News

Does CBD Cause Liver Damage?

January 4, 2021 by CBD OIL

A major concern about cannabidiol (CBD) involves liver safety. And a study on this topic carried out by researchers at the University of Arkansas for Medical Sciences has had rippling effects across the CBD community, leading many to wonder if CBD is as safe as they thought.

Here, we break down the science of these results:

In this study, 8-week-old male mice (considered to be the equivalent age of adult humans) were given different dosages of a concentrated CBD-enriched extract.[1] Acute toxicity (24h) as well as sub-acute toxicity (10 days) was investigated. CBD doses were chosen to provide estimated equivalency to human doses.

The highest dose (2,460 mg/kg) showed clear evidence of acute liver toxicity. Lower doses did not show similar results administered acutely; however, given over a 10-day duration, lower doses also showed signs of liver toxicity.

The researchers concluded that “despite the beneficial effects of CBD in the treatment of certain therapy-resistant seizures, it poses a risk for liver injury. Furthermore, the probability of CBD-drug interactions appears quite high.”[1]

The results of this mouse study has raised a lot of eyebrows so we have outlined its limitations here:

The dose in the study was unrealistic.

The first point of contention is the dose of CBD that was used in this study. The maximum dose equivalent is way above what is normally consumed by most CBD users. The authors even noted that the dose of “200 mg/kg CBD is not applicable to most real-life scenarios.”[1]

Many drugs taken in excessive amounts could cause liver damage.

Paracetamol, which is a common over-the-counter drug, is known to cause liver damage when taken in high doses acutely or over a prolonged duration of time.[2] And this is true for many, many products.

Epidiolex®, prescription CBD for epilepsy, can also cause abnormal liver values and there is indeed a warning on the medication label concerning elevated liver values. However, since this is prescribed for severe epilepsy (thus requiring a high dosage), a doctor must recommend the medication to a patient and monitor their liver values before and during treatment.

One study alone should not cause panic.

The results from this study should instead serve to inform the public that toxicity at high doses should be a concern as with other medications. Caution should also be exercised when taking CBD together with other medication, as it can cause interactions.

We always recommend speaking to your doctor before starting CBD or medical cannabis and always, always remember the tips on how to buy quality CBD.

Image Credit: Steve Buissinne

Image Source: https://pixabay.com/photos/capsule-pill-health-medicine-1079838/

References

  1. Ewing LE et al. (2019): Hepatotoxicity of a cannabidiol-rich cannabis extract in the mouse model. 2019;24(9):1694.
  2. Tanne J. Paracetamol causes most liver failure in UK and US. BMJ. 2016;332(7542):628.

Filed Under: CBD Health

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 91
  • Go to page 92
  • Go to page 93
  • Go to page 94
  • Go to page 95
  • Interim pages omitted …
  • Go to page 116
  • Go to Next Page »

Footer

  • Home
  • Privacy Policy
  • Terms of Service